Sökning: onr:"swepub:oai:DiVA.org:kth-346508" >
Design and synthesi...
-
Iqbal, ShaziaTrustlife Labs Drug Research & Development Center, 34774 Istanbul, Turkiye
(författare)
Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma
- Artikel/kapitelEngelska2024
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2024
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:kth-346508
-
https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-346508URI
-
https://doi.org/10.1016/j.bioorg.2024.107425DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
QC 20240520
-
Non-alcoholic fatty liver disease (NAFLD) comprises a broad range of liver disease including hepatocellular carcinoma (HCC) with is no FDA-approved drug. Liver pyruvate kinase (PKL) is a major regulator of metabolic flux and ATP generation in liver presenting a potential target for the treatment of NAFLD. Based on our recent finding of JNK-5A's effectiveness in inhibiting PKLR expression through a drug repositioning pipeline, this study aims to improve its efficacy further. We synthesized a series of JNK-5A analogues with targeted modifications, guided by molecular docking studies. These compounds were evaluated for their activities on PKL expression, cell viability, triacylglyceride (TAG) levels, and the expressions of steatosis-related proteins in the human HepG2 cell line. Subsequently, the efficacy of these compounds was assessed in reducing TAG level and toxicity. Compounds 40 (SET-151) and 41 (SET-152) proved to be the most efficient in reducing TAG levels (11.51 ± 0.90 % and 10.77 ± 0.67 %) and demonstrated lower toxicity (61.60 ± 5.00 % and 43.87 ± 1.42 %) in HepG2 cells. Additionally, all synthesized compounds were evaluated for their anti-cancer properties revealing that compound 74 (SET-171) exhibited the highest toxicity in cell viability with IC50 values of 8.82 µM and 2.97 µM in HepG2 and Huh7 cell lines, respectively. To summarize, compounds 40 (SET-151) and 41 (SET-152) show potential for treating NAFLD, while compound 74 (SET-171) holds potential for HCC therapy.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Sebhaoui, JihadTrustlife Labs Drug Research & Development Center, 34774 Istanbul, Turkiye; Life and Health Sciences Laboratory, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaadi University, Morocco
(författare)
-
Ashraf, SajdaTrustlife Labs Drug Research & Development Center, 34774 Istanbul, Turkiye
(författare)
-
Özcan, MehmetKTH,Science for Life Laboratory, SciLifeLab,Department of Medical Biochemistry, Faculty of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkiye(Swepub:kth)u1ilte0b
(författare)
-
Kim, WoongheeKTH,Systembiologi,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1nic2pk
(författare)
-
Belmen, BurcuTrustlife Labs Drug Research & Development Center, 34774 Istanbul, Turkiye
(författare)
-
Yeşilyurt, GüldenizTrustlife Labs Drug Research & Development Center, 34774 Istanbul, Turkiye
(författare)
-
Hanashalshahaby, EssamTrustlife Labs Drug Research & Development Center, 34774 Istanbul, Turkiye
(författare)
-
Zhang, ChengKTH,Systembiologi,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1ww5kvp
(författare)
-
Uhlén, MathiasKTH,Systembiologi,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1dulvmw
(författare)
-
Boren, JanDepartment of Molecular and Clinical Medicine, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden
(författare)
-
Turkez, HasanDepartment of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkiye
(författare)
-
Mardinoglu, AdilKTH,Systembiologi,Science for Life Laboratory, SciLifeLab,Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London SE1 9RT, UK(Swepub:kth)u1t8kmr6
(författare)
-
Trustlife Labs Drug Research & Development Center, 34774 Istanbul, TurkiyeTrustlife Labs Drug Research & Development Center, 34774 Istanbul, Turkiye; Life and Health Sciences Laboratory, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaadi University, Morocco
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Bioorganic chemistry: Elsevier BV1470045-2068
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Iqbal, Shazia
-
Sebhaoui, Jihad
-
Ashraf, Sajda
-
Özcan, Mehmet
-
Kim, Woonghee
-
Belmen, Burcu
-
visa fler...
-
Yeşilyurt, Gülde ...
-
Hanashalshahaby, ...
-
Zhang, Cheng
-
Uhlén, Mathias
-
Boren, Jan
-
Turkez, Hasan
-
Mardinoglu, Adil
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Gastroenterologi
- Artiklar i publikationen
-
Bioorganic chemi ...
- Av lärosätet
-
Kungliga Tekniska Högskolan